{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:05:50Z","timestamp":1792101950338,"version":"4.4.0"},"reference-count":53,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,8,31]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>rhTPO is a potentially effective and safe treatment option for ITP during pregnancy.<\/jats:p>","DOI":"10.1182\/blood-2017-01-761262","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T20:50:17Z","timestamp":1497905417000},"page":"1097-1103","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":95,"title":["A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy"],"prefix":"10.1182","volume":"130","author":[{"given":"Zhangyuan","family":"Kong","sequence":"first","affiliation":[{"name":"Department of Hematology, Qilu Hospital, Shandong University, Jinan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital, Shandong University, Jinan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital, Shandong University, Jinan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital, Shandong University, Jinan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[{"name":"Shiyan People\u2019s Hospital, Shiyan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchi","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Luo","sequence":"additional","affiliation":[{"name":"The Second Hospital of Hebei Medical University, Shijiazhuang, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichun","family":"Li","sequence":"additional","affiliation":[{"name":"People's Hospital of Puyang, Puyang, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochao","family":"Ji","sequence":"additional","affiliation":[{"name":"People's Hospital of Puyang, Puyang, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongguang","family":"Cui","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Qingdao University, Qingdao, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Bai","sequence":"additional","affiliation":[{"name":"Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Wu","sequence":"additional","affiliation":[{"name":"Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital, Shandong University, Jinan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital, Shandong University, Jinan, China;"},{"name":"Key Laboratory of Cardiovascular Remolding and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital, Shandong University, Jinan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[{"name":"Harbin Institute of Hematology & Oncology, Harbin the First Hospital, Harbin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital, Shandong University, Jinan, China;"},{"name":"Shandong Province Key Laboratory of Hematology\/Immunology, Creative Studio of Scientific and Technologic Leading Talents, Qilu Hospital, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111905252428100_B1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2141.2006.06024.x","article-title":"The pathogenesis of immune thrombocytopaenic purpura","volume":"133","author":"Cooper","year":"2006","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111905252428100_B2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood.V81.5.1246.1246","article-title":"Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment","volume":"81","author":"Berchtold","year":"1993","journal-title":"Blood"},{"issue":"26","key":"2019111905252428100_B3","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111905252428100_B4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP","volume":"103","author":"McMillan","year":"2004","journal-title":"Blood"},{"issue":"9","key":"2019111905252428100_B5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"issue":"11","key":"2019111905252428100_B6","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2019111905252428100_B7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0268-960X(96)90015-6","article-title":"Thrombocytopenia in pregnancy: diagnosis, pathogenesis and management","volume":"10","author":"Crowther","year":"1996","journal-title":"Blood Rev"},{"issue":"1","key":"2019111905252428100_B8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1054\/blre.2001.0181","article-title":"Idiopathic thrombocytopenic purpura complicating pregnancy","volume":"16","author":"Kelton","year":"2002","journal-title":"Blood Rev"},{"issue":"Suppl 1","key":"2019111905252428100_B9","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/00043426-200312001-00008","article-title":"Idiopathic thrombocytopenic purpura in adults","volume":"25","author":"Provan","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"2019111905252428100_B10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0037-1963(00)90106-9","article-title":"Management of idiopathic thrombocytopenic purpura in pregnancy","volume":"37","author":"Gill","year":"2000","journal-title":"Semin Hematol"},{"issue":"2","key":"2019111905252428100_B11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111905252428100_B12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2016-04-710285","article-title":"Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy","volume":"128","author":"Sun","year":"2016","journal-title":"Blood"},{"issue":"10","key":"2019111905252428100_B13","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V100.10.3457","article-title":"Recombinant human thrombopoietin: basic biology and evaluation of clinical studies","volume":"100","author":"Kuter","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2019111905252428100_B14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12185-012-1124-8","article-title":"A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia","volume":"96","author":"Wang","year":"2012","journal-title":"Int J Hematol"},{"issue":"1","key":"2019111905252428100_B15","first-page":"5","article-title":"The study of biological activity of recombinant human thrombopoietin in vivo","volume":"24","author":"Chen","year":"2001","journal-title":"J Bran Camp First Mil Med Univ"},{"issue":"2","key":"2019111905252428100_B16","first-page":"89","article-title":"[Consensus of Chinese experts on diagnosis and treatment of adult primary immune thrombocytopenia (version 2016)]","volume":"37","author":"Thrombosis and Hemostasis Group, Hematology Society, Chinese Medical Association","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"4","key":"2019111905252428100_B17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2141.2010.08234.x","article-title":"Thromboembolic events are not uncommon in patients with immune thrombocytopenia","volume":"150","author":"Thachil","year":"2010","journal-title":"Br J Haematol"},{"key":"2019111905252428100_B18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-3476(63)80093-1","article-title":"Gesell developmental testing","volume":"62","author":"Wilson","year":"1963","journal-title":"J Pediatr"},{"issue":"4","key":"2019111905252428100_B19","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1182\/blood-2005-12-015222","article-title":"Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience","volume":"109","author":"Mazzucconi","year":"2007","journal-title":"Blood"},{"issue":"7","key":"2019111905252428100_B20","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V99.7.2599","article-title":"Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor","volume":"99","author":"Basser","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2019111905252428100_B21","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","article-title":"Thrombocytopenia caused by the development of antibodies to thrombopoietin","volume":"98","author":"Li","year":"2001","journal-title":"Blood"},{"issue":"12","key":"2019111905252428100_B22","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.intimp.2011.10.014","article-title":"Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin","volume":"11","author":"Shin","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"2019111905252428100_B23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1182\/blood-2014-06-581868","article-title":"A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP","volume":"125","author":"Zhou","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2019111905252428100_B24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3904\/kjim.2005.20.2.129","article-title":"Clinical aspects of pregnancy and delivery in patients with chronic idiopathic thrombocytopenic purpura (ITP)","volume":"20","author":"Won","year":"2005","journal-title":"Korean J Intern Med"},{"issue":"4","key":"2019111905252428100_B25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02982137","article-title":"Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates","volume":"75","author":"Fujimura","year":"2002","journal-title":"Int J Hematol"},{"issue":"2","key":"2019111905252428100_B26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00404-013-2958-x","article-title":"Pregnancy outcome in patients with idiopathic thrombocytopenic purpura","volume":"289","author":"Subbaiah","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"2019111905252428100_B27","first-page":"284","article-title":"Pharmacokinetics after a single subcutaneous injection of recombinant human thrombopoietin in human","volume":"17","author":"Jiang","year":"2001","journal-title":"Zhongguo Lin Chuang Yao Li Xue Za Zhi"},{"issue":"4","key":"2019111905252428100_B28","first-page":"318","article-title":"[Metabolism, distribution and excretion of recombinant human thrombopoietin in mice]","volume":"9","author":"Liu","year":"2001","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"5","key":"2019111905252428100_B29","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1572-0241.2007.01756.x","article-title":"Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes","volume":"103","author":"Reddy","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2019111905252428100_B30","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/gut.2006.105288","article-title":"Cyclosporin A treatment of steroid-refractory ulcerative colitis during pregnancy: report of two cases","volume":"56","author":"Reindl","year":"2007","journal-title":"Gut"},{"issue":"5","key":"2019111905252428100_B31","first-page":"708","article-title":"Azathioprine therapy complicated by pregnancy","volume":"40","author":"Erkman","year":"1972","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2019111905252428100_B32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00007890-197604000-00004","article-title":"Immunosuppressive drugs and the foetus","volume":"21","author":"Price","year":"1976","journal-title":"Transplantation"},{"issue":"2","key":"2019111905252428100_B33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0016-5085(90)91027-4","article-title":"Safety of azathioprine in pregnancy in inflammatory bowel disease","volume":"99","author":"Alstead","year":"1990","journal-title":"Gastroenterology"},{"issue":"2 Pt 2","key":"2019111905252428100_B34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/AOG.0b013e31828d5b56","article-title":"Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy","volume":"122","author":"Patil","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2 Pt 2 Suppl 1","key":"2019111905252428100_B35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/AOG.0000000000000371","article-title":"Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy","volume":"124","author":"Decroocq","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"8","key":"2019111905252428100_B36","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMct1014202","article-title":"Thrombopoietin-receptor agonists for primary immune thrombocytopenia","volume":"365","author":"Imbach","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111905252428100_B37","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood-2008-04-150078","article-title":"Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP","volume":"113","author":"Bussel","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2019111905252428100_B38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1182\/blood-2016-03-704734","article-title":"Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia","volume":"128","author":"Mah\u00e9vas","year":"2016","journal-title":"Blood"},{"issue":"9610","key":"2019111905252428100_B39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial","volume":"371","author":"Kuter","year":"2008","journal-title":"Lancet"},{"issue":"9664","key":"2019111905252428100_B40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","article-title":"Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Bussel","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"2019111905252428100_B41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1440-1746.2012.07246.x","article-title":"Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis","volume":"28","author":"Moussa","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"2019111905252428100_B42","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1538-7836.2010.03830.x","article-title":"Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)","volume":"8","author":"Gernsheimer","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111905252428100_B43","first-page":"608","article-title":"[A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura]","volume":"43","author":"Zhao","year":"2004","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"3","key":"2019111905252428100_B44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12185-010-0684-8","article-title":"A retrospective analysis of obstetric patients with idiopathic thrombocytopenic purpura: a single center study","volume":"92","author":"Fujita","year":"2010","journal-title":"Int J Hematol"},{"issue":"1","key":"2019111905252428100_B45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MBC.0b013e32835975d6","article-title":"Diagnosis and treatment of intracranial hemorrhage in children with hemophilia","volume":"24","author":"Nagel","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"2019111905252428100_B46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2141.2002.03674.x","article-title":"The investigation and management of neonatal haemostasis and thrombosis","volume":"119","author":"Williams","year":"2002","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111905252428100_B47","first-page":"934","article-title":"[Consensus report for the management of pregnancy with primary immune thrombocytopenia]","volume":"55","author":"Miyakawa","year":"2014","journal-title":"Rinsho Ketsueki"},{"issue":"16","key":"2019111905252428100_B48","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa054626","article-title":"AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP","volume":"355","author":"Bussel","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111905252428100_B49","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s11095-011-0420-y","article-title":"Investigation of the pharmacokinetics of romiplostim in rodents with a focus on the clearance mechanism","volume":"28","author":"Wang","year":"2011","journal-title":"Pharm Res"},{"issue":"2","key":"2019111905252428100_B50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:25:2:097","article-title":"Transcytosis and catabolism of antibody","volume":"25","author":"Ghetie","year":"2002","journal-title":"Immunol Res"},{"issue":"9","key":"2019111905252428100_B51","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2019111905252428100_B52","first-page":"249","article-title":"FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions","volume":"382","author":"Challa","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"issue":"9","key":"2019111905252428100_B53","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40262-016-0382-7","article-title":"Development of romiplostim for treatment of primary immune thrombocytopenia from a pharmacokinetic and pharmacodynamic perspective","volume":"55","author":"Yang","year":"2016","journal-title":"Clin Pharmacokinet"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/9\/1097\/1405159\/blood761262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/9\/1097\/1405159\/blood761262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T17:20:21Z","timestamp":1719249621000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/9\/1097\/36996\/A-novel-recombinant-human-thrombopoietin-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,8,31]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-01-761262","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727734841.793541345","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]}}}